Phase II study of megestrol acetate for metastatic carcinoma of the prostate. 1987

C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen

Forty-three males with recurrent and metastatic cancer of the prostate were treated with megestrol acetate (160 mg/day orally) after having failed first-line hormonal treatment (orchiectomy or diethylstilboestrol). Thirty-seven patients were evaluated objectively for response, 28 of whom received the drug for more than 6 weeks. One patient had a partial response (National Prostatic Cancer Project criteria) and seven had stable disease. Toxicity was usually mild, although five patients developed a transient rise in liver enzymes and one patient had a grand mal fit. Three patients showed evidence of tumour "flare". Megestrol acetate has only limited efficacy in patients previously treated for prostatic cancer by hormonal manipulation.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008535 Megestrol A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione,Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D019290 Megestrol Acetate Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) Apo-Megestrol,Borea,Lin-Megestrol,Maygace,Megace,Megefren,Megestat,Megostat,Mestrel,Nu-Megestrol,Acetate, Megestrol,Apo Megestrol,ApoMegestrol,Lin Megestrol,LinMegestrol,Nu Megestrol,NuMegestrol

Related Publications

C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
January 1992, Oncology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
April 1997, Journal of gastroenterology and hepatology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
March 1990, British journal of urology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
January 1975, Journal of surgical oncology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
January 1994, European journal of cancer (Oxford, England : 1990),
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
August 1991, Breast cancer research and treatment,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
August 1990, Cancer,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
April 1998, American journal of clinical oncology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
December 1986, Seminars in oncology,
C Crombie, and D Raghavan, and J Page, and R Woods, and D Dalley, and R Devine, and M Rosen
January 1977, Medical and pediatric oncology,
Copied contents to your clipboard!